LP
ELV icon

LMR Partners’s Elevance Health ELV Stock Holding History

LMR Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,400
Closed -$1.19M – 1591
2025
Q4 		$1.19M Hold
3,400
– – ﹤0.01% 943
2025
Q3 		$1.1M Hold
3,400
– – ﹤0.01% 897
2025
Q2 		$1.32M Buy
3,400
+2,500
+278% +$1.01M 0.01% 733
2025
Q1 		$391K Hold
900
– – ﹤0.01% 958
2024
Q4 		$332K Hold
900
– – ﹤0.01% 888
2024
Q3 		$468K Buy
+900
New +$481K ﹤0.01% 845
2024
Q2 		– Sell
-7,600
Closed -$3.94M – 1154
2024
Q1 		$3.94M Hold
7,600
– – 0.04% 395
2023
Q4 		$3.58M Hold
7,600
– – 0.04% 387
2023
Q3 		$3.31M Buy
+7,600
New +$3.45M 0.04% 329

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

LMR Partners's ELV Position: Q1 2026 in Review

LMR Partners reduced its Elevance Health (ELV) stake by 56% in Q1 2026, selling an estimated $3.29M and leaving 7,887 shares worth $2.31M. The position accounts for 0.01% of the portfolio, ranked #828.

LMR Partners first reported a position in ELV in Q2 2014 and has held it in 35 quarters since. The position peaked at $9.44M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • LMR Partners held 7,887 shares of Elevance Health worth $2.31M as of Q1 2026.
  • LMR Partners sold 10,000 Elevance Health shares in Q1 2026, an estimated $3.29M.
  • Elevance Health made up 0.01% of LMR Partners's portfolio in Q1 2026, its #828 holding.
  • LMR Partners first reported a position in Elevance Health in Q2 2014 and has held it in 35 quarters since.
  • LMR Partners's Elevance Health position peaked at $9.44M in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.